CClinicalTrials.gg
RecruitingNCT06785376P3Updated Aug 31, 2026

P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention

An interventional study of DIY (Do It Yourself) and TRUST in HIV Testing and PrEP Uptake, sponsored by Columbia University. Recruiting at 1 site in United States. Open to male participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by Columbia University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
480
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Male
01

Study summary

The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP/PrEP uptake by combining existing evidence-based and novel evidence-informed components and integrating them into a community-based organization's (CBO) standard of care (SOC) PEP/PrEP navigation program. The evaluation will apply use a 2x2 factorial design to randomize and follow for 18 months 480 PrEP-eligible Black MSM (aged 18-65) living in the NYC area to one of four combinations of interventions. The impact of the social/media campaign, delivered to both geographic (print media) and Black MSM communities (social media) and launched midway through recruitment, will be assessed through assessment of timing and length of exposure as covariates in analysis.

Read the detailed description

The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP/PrEP uptake by combining existing evidence-based and novel evidence-informed components and integrating them into a community-based organization's (CBO) standard of care (SOC) PEP/PrEP navigation program. The existing evidence-based, individual-level component is TRUST (R01 DA-038108), a single-session peer-based HIV self-testing intervention for Black MSM. The existing, evidence-based community-level component is a social/print media campaign (CHHANGE [R21 MH-102182-01] \& PEPTALK [R21 AI-122996]) to reduce community-level HIV stigma and drive demand for HIV testing, PEP and PrEP. The novel, evidence-informed, individual-level component is "Do It Yourself (DIY)", a 3-session enhancement of the CBO SOC peer navigation program that promotes empowerment, autonomy, stigma coping/resistance and social support via a novel "sexual self-care in-a-box" and peer-to-peer training to increase HIV testing and PEP/PrEP uptake.

The Specific Aims are:

  1. Component test DIY, adapt social/print media campaign \& manualize full intervention. Modified intervention mapping, component testing and post-test interviews with 20 PrEP-eligible Black MSM (for DIY) and focus groups with 20 PrEP-eligible Black MSM (for media campaign adaptation) will be conducted. A 15-person community consulting group of Black MSM, community leaders, media professionals, and service providers, will provide feedback on both components and the full manualized intervention.
  2. Estimate main and interactive effects of components on recent HIV testing and PEP/PrEP uptake.

    Hypothesis 1: Exposure to TRUST, DIY, and the media campaign will each be associated with (1) higher past 3-month HIV testing; and (2) shorter time to PrEP uptake over time.

    Hypothesis 2: A multiplicative interaction among TRUST, DIY and length of exposure to the media campaign will emerge, such that exposure to combination of multiple interventions will be associated with the more positive outcomes compared to the impact of each intervention component individually.

    To test this hypotheses, this study will use a 2x2 factorial design to randomize and follow for 18 months 480 PrEP-eligible Black MSM (aged 18-65) living in NYC to one of four combinations: 1) SOC, DIY \& TRUST; 2) SOC \& TRUST (no DIY); 3) SOC \& DIY (no TRUST); 4) SOC ALONE (no TRUST and no DIY). Hypotheses will be tested via regression (GEE) and Cox proportional hazard models; impact of the social/media campaign, delivered to both geographic (print media) and Black MSM communities (social media) and launched midway through recruitment, will be assessed through assessment of timing and length of exposure as covariates in the regression models and through interrupted time series methods.

  3. Describe the feasibility, acceptability, and usability of intervention components and package via the Re-AIM implementation framework with an emphasis on component implementation by a CBO program.
02

Conditions studied

  • HIV Testing
  • PrEP Uptake

Browse trials for

Keywords

  • HIV testing
  • PrEP uptake
  • HIV prevention
  • men who have sex with men
03

In context

Homosexuality

28 studies on the registry are indexed under Homosexuality; 6 are open to participants now.

This study's planned enrollment of 480 is above the median of 288 across 25 interventional studies indexed under Homosexuality.

Browse Homosexuality studies →

Lead sponsor

Columbia University is the lead sponsor of 1,103 studies on the registry; 193 are open to participants now.

Of its 172 completed or terminated interventional studies of FDA-regulated products, 142 (83%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Assigned biological male sex at birth
  • 18-65 years of age
  • Self-identify as: Black, African-American, Afro-Caribbean, Black African, Afro-Latino or multiethnic Black
  • Reside in the NYC metro area
  • Not HIV-positive (tested before randomization)
  • Report insertive or receptive anal intercourse with another man in the past six months
  • Not currently on PEP or PrEP
  • Can communicate in English or Spanish
  • Provide informed consent for the study
  • Any sexual identity

Exclusion criteria

Exclusion Criteria:

  • Unable to conduct a rapid HIV-self test to confirm self-reported HIV-negative status
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
480 participants (estimated)

Study arms

  • Active comparator
    A. SOC

    Standard of care single-session, low threshold peer/near-peer navigation to PrEP.

    Behavioral: SOC

  • Experimental
    B. SOC & TRUST

    SOC standard of care single-session, low threshold peer/near-peer navigation to PrEP; TRUST single-session HIV self-testing training with facilitator

    Behavioral: TRUST · Behavioral: SOC

  • Experimental
    C. SOC & DIY

    SOC standard of care single-session, low threshold peer/near-peer navigation to PrEP; DIY three-session sexual health promotion/HIV prevention training with facilitator

    Behavioral: DIY (Do It Yourself) · Behavioral: SOC

  • Experimental
    D. SOC, TRUST & DIY

    SOC standard of care single-session, low threshold peer/near-peer navigation to PrEP; TRUST single-session HIV self-testing training with facilitator; DIY three-session sexual health promotion/HIV prevention training with facilitator

    Behavioral: DIY (Do It Yourself) · Behavioral: TRUST · Behavioral: SOC

Interventions

  • BehavioralDIY (Do It Yourself)

    DIY is 3-session program that promotes empowerment, autonomy, stigma coping/resistance and social support to promote sexual health and pleasure and HIV prevention.

  • BehavioralTRUST

    TRUST is a single-session HIV self-testing training with facilitator

  • BehavioralSOC

    standard of care single-session, low threshold peer/near-peer navigation to PrEP.

06

What researchers measure

Primary outcomes

  1. P3M HIV testing

    did the participant engage in HIV testing in the past 3 months

    Time frame: past 3 months

  2. PrEP uptake

    PrEP uptake (yes/no)/time to PrEP uptake (assessed via self-report, medical record)

    Time frame: past 3 months

Secondary outcomes

  1. consistent HIV testing

    consistent HIV testing (2+ tests 3 months apart in 9 months)

    Time frame: over 9 months

  2. PEP uptake

    PEP uptake (self-report, medical record)

    Time frame: past 3 months

  3. PrEP and PEP adherence

    PrEP/PEP adherence (self-report/medical record)

    Time frame: past 3 months

07

Study locations

1 of 1 sites recruiting
  • Columbia University
    New York, New York 10027, United States
    • Victoria Frye, MPH, DrPH · Contact · vaf5@columbia.edu · 2128534490
    • Victoria Frye, MPH, DrPH · Principal investigator
    Recruiting
08

References and documents

Publications

  • Bond KT, Williams PM, Paige M, Lam I, Hart K, Matthews D, Smith W, Koffler E, Zhang H, Kelvin EA, Frye V, Duncan DT. Designing Pleasure-Centered, Culturally Relevant PrEP Messaging for Black Gay, Bisexual, Queer, Same-Gender-Loving, and Other Men Who have Sex with Men (SGL/MSM) in New York City. AIDS Behav. 2026 Aug;30(8):2513-2523. doi: 10.1007/s10461-026-05077-7. Epub 2026 Apr 17. PubMed 41995922 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06785376
Lead sponsor
Columbia University
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Victoria Anne Frye (Professor of Social Work, Columbia University) — Principal investigator
First posted
Jan 21, 2025
Start date
Dec 19, 2024
Primary completion
Feb 28, 2028 (estimated)
Completion
Feb 28, 2028 (estimated)
Last update
Aug 31, 2026

Study contacts

Victoria Frye, MPH, DrPH
Contact
vaf5@columbia.edu
2128534490

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion